ABSTRACT
Objectives To provide the first known comprehensive analysis of COVID-19 outcomes in a federal penitentiary system. We examined the following COVID-19 outcomes within federal penitentiaries in Canada and contrasted them with estimates for the overall population in the penitentiaries’ respective provincial jurisdictions: testing, prevalence, the proportion recovered, and fatality.
Methods Data for prisons were obtained from the Correctional Service of Canada and, for the general population, from the Esri COVID-19 Canadian Outbreak Tracking Hub. Data were retrieved between March 30 and April 21, 2020, and are accurate to this date. Penitentiary-, province- and sex-specific frequency statistics for each outcome were calculated.
Results Data on 50 of 51 penitentiaries (98%) were available. Of these, 72% of penitentiaries reported fewer tests per 1000 population than the Canadian general population average (16 tests/1000 population), and 24% of penitentiaries reported zero tests. Penitentiaries with high levels of testing were those that already had elevated COVID-19 prevalence. Five penitentiaries reported an outbreak (at least one case). Hardest hit penitentiaries were those in Quebec, Ontario, and British Columbia, with some prisons reporting COVID-19 prevalence of 30% to 40%. Of these, two were women’s prisons. Female prisoners were over-represented among cases (31% of cases overall, despite representing 5% of the total prison population).
Conclusion Increased sentinel or universal testing may be appropriate given the confined nature of prison populations. This, along with rigorous infection prevention control practices and the potential release of prisoners, will be needed to curb current outbreaks and those likely to come.
Between 20% and 57% fewer tests per 1000 population have been conducted in federal prisons in Saskatchewan, New Brunswick, Nova Scotia and Alberta than in the general population of those provinces.
Though Alberta, Manitoba, Saskatchewan, New Brunswick and Nova Scotia are reporting lower counts of COVID-19 cases, these are also the regions reporting the lowest levels of testing.
Case incidence has been highest in federal prisons in Quebec, Ontario, and British Columbia, where a total of five prisons are experiencing outbreaks (1 or more cases). These regions are those reporting the highest levels of testing – higher than the testing levels in the general population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
AB receives postdoctoral funding from the Fonds de Recherche du Québec-Santé is supported by the Canada Research Chair in Population Health Equity.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Datasets analyzed and generated during this study are included in the supplementary materials.
